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Background: Insulin resistance plays an important role in the development of metabolic syndrome (MS). Fu Fang
Zhen Zhu Tiao Zhi formula (FTZ), a Chinese medicinal decoction, has been used to relieve hyperlipidemia,
atherosclerosis and other symptoms associated with metabolic disorders in the clinic.
Methods: To evaluate the effect of FTZ on insulin resistance, HepG2 cells were induced with high insulin as a
model of insulin resistance and treated with FTZ at one of three dosages. Next, the levels of glucose content,
insulin receptor substrate1 (IRS1) protein expression and phosphatidylinositol 3-kinase (PI3K) subunit p85 mRNA
expression were measured. Alternatively, MS was induced in rats via gavage feeding of a high-fat diet for four
consecutive weeks followed by administration of FTZ for eight consecutive weeks. Body weight and the plasma
levels of lipids, insulin and glucose were evaluated. Finally, the expression of PI3K p85 mRNA in adipose tissue of
rats was measured.
Results: Our results revealed that FTZ attenuated glucose content and up-regulated the expression of PI3K p85
mRNA and IRS1 protein in insulin-resistant HepG2 cells in vitro. Moreover, FTZ reduced body weight and the
plasma concentrations of triacylglycerol, cholesterol, fasting glucose and insulin in insulin resistant MS rats. FTZ also
elevated the expression of PI3K p85 mRNA in the adipose tissues of MS rats.
Conclusion: FTZ attenuated MS symptoms by decreasing the plasma levels of glucose and lipids. The underlying
mechanism was attenuation of the reduced expression of PI3K p85 mRNA and IRS1 protein in both insulin-resistant
HepG2 cells and MS rats.
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Reaven noted that dyslipidemia, hypertension and
hypertriglyceridemia often occurred together [1]. Conse-
quently, this author proposed the concept of X Syndrome,
regarding insulin resistance as the primary characteristic
of X Syndrome. Based on the association of X syndrome
with a variety of metabolic diseases, Zimmet et al. defined
its symptoms as metabolic syndrome (MS). MS is related
to excessive energy intake, a sedentary lifestyle, and* Correspondence: gyguoyz@163.com
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unless otherwise stated.multiple genetic factors [2]. Many studies have demon-
strated that patients with MS displayed an increased risk
of developing diabetes, cardiovascular disease and other
diseases. Insulin resistance (IR) has been suggested as the
common pathophysiological basis of MS. Because there is
no eutherapeutic Western medicine to treat MS, searching
for an effective therapeutic among the traditional Chinese
medicines (TCMs) or botanicals is urgently required.
Fu Fang Zhen Zhu Tiao Zhi formula (FTZ), for which
a patent has been issued, is composed of eight medical
herbs and has been proven clinically effective for the
treatment of dyslipidemia [3,4]. Our previous study
demonstrated that FTZ could reduce serum levels of
total cholesterol (TC), triglycerides (TG) and low-
density lipoprotein cholesterol (LDL-C) and increase theThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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(HDL-C) in hyperlipidemic patients [5,6]. FTZ could re-
duce the viscosity of plasma and whole blood in hyper-
lipidemic patients [7]. In addition, our previous studies
also demonstrated the antioxidant properties of FTZ,
which reduced the oxidation of LDL-C [8]. FTZ also
could improve serum lipid profile in high lipid diet in-
duced hyperlipidemic rats by regulating the HMG-CoA
reductase and CYP7A1 [9].
MS includes the symptoms dyslipidemia, hypertension
and hypertriglyceridemia and is typically characterized
by insulin resistance. Therefore, insulin resistance is sug-
gested to be a new drug target for treatment of MS or
dyslipidemia. Nevertheless, the effect and mechanisms of
FTZ on MS and insulin resistance remain unclear.
To elucidate the effect of FTZ on insulin resistance
and its mechanism of action, HepG2 cells with insulin
resistance and MS rats were used, and the effect of FTZ
on insulin-resistant HepG2 cells and MS rats was mea-
sured. Moreover, the resistance index, the gene expres-
sion level of PI3K and the protein expression level of
IRS1 were also investigated.
Methods
Materials
HepG2 cells were purchased from the American Type
Culture Collection (ATCC) bioresource center (Manassas,
VA, USA). Dulbecco’s modified Eagle’s medium (DMEM)
and fetal bovine serum (FBS) were purchased from Invi-
trogen (Carlsbad, CA, USA). IRS1 and GADPH antibodies
were from Abcam Inc. (Cambridge, MA, USA). Insulin
and rosiglitazone (RGS) were purchased from Sigma (St.
Louis, MO, USA). All other reagents were analytical grade.
Preparation of FTZ extract
Herbs in FTZ [composed of Ligustrum lucidum W.T.
Aiton, fructus; Atractylodes macrocephala Koidz., rhizoma;
Salvia miltiorhiza Bunge, radix; Coptis chinensis Franch.,
rhizoma; Panax notoginseng (Burk.)F.H.Chen, radix; Eucom-
mia ulmoides Oliv., cortex; Cirsium japonicum (Thunb.)
Fisch. ex DC., radix; Citrus medica var. sarcodactylus
(Siebold ex Hoola van Nooten) Swingle, fructus] were
provided by Zhixin Chinese Herbal Medicine Co.,Ltd.
(Guangzhou, China) and authenticated by Professor
Shuyan Li, pharmacognosist of School of Chinese Me-
dicinal Sciences, Guangdong Pharmaceutical University.
All of the raw materials in FTZ were examined accord-
ing to the quality control criteria of Chinese Pharmaco-
peia 2010 and were controlled as previously reported
[10]. The FTZ extract was prepared via alcohol and
water extraction of eight herbs according to the proto-
col (see Supporting Material for the protocol of FTZ
preparation). FTZ was obtained from the Institute of
Materia Medica, Guangdong Pharmaceutical University.The voucher specimens were GDPUZYY 20110901-8
(see Supporting Material-Voucher specimen). Quality
analysis of the FTZ extract was performed via HPLC
fingerprinting, which was obtained using a HPLC unit
(Waters, USA) with an Agilent HC-C18 column (4.6
mm × 250 mm, 5 μm). All assigned peaks were identi-
fied by performing a co-injection test with authentic
samples and comparative analysis of the UV spectral
data (see Supporting Material-HPLC conditions) [9].
Cell culture
The human hepatocellular carcinoma cell line HepG2
was purchased from ATCC. Cells were cultured in
DMEM supplemented with 10% heat-inactivated fetal
FBS at 37°C in a 5% CO2 atmosphere. In all experiments,
cells grew to 80-90% confluence.
Induction of insulin-resistance in HepG2 cells and glucose
uptake experiments
Insulin resistance was induced in HepG2 cells as previ-
ously described [11-13]. In brief, HepG2 cells were seeded
on 24-well plates at 2 × 105 cells/well, incubated for 24 h to
reach maximal confluence and serum-starved for another
24 h. The cells were then incubated for 36 h in serum-free
DMEM containing 25 mmol/l d-glucose, 10-6mol/l insulin
in the absence or presence of 1, 25 and 100 μg/ml FTZ or
10 μmol/l RGS. FTZ administration at 100, 25 and 1 μg/ml
were defined as high, medium and low dosages, respect-
ively. Next, cells were washed twice with PBS. The cells
were then incubated for 24 h in serum-free DMEM without
phenol red. The glucose content was quantified using a
GOD-POD kit, measuring optical absorbance at 505 nm.
Western blot analysis
Cells were washed with ice-cold PBS and lysed with lysis
buffer (50 mmol/l Tris HCl, 1% Triton X-100, 0.5% so-
dium deoxycholate, 150 mmol/l NaCl, 1 mmol/l EDTA, 1
mmol/l PMSF, 1 mmol/l sodium orthovanadate, 1 mmol/l
NaF and 0.2% protease inhibitor cocktail; pH7.2). For
western blotting, protein samples (20 μg) of high insulin-
induced insulin-resistant HepG2 cells were separated via
10% sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE). The proteins were transferred to a
PVDF membrane and incubated with primary antibody
(anti-IRS1, or anti-GAPDH), followed by secondary anti-
body (horseradish peroxidase-conjugated anti-rabbit
IgG). Intensity of the immunoblot signal was assayed
using Western Bright™ ECL spray and analyzed quantita-
tively using GeneTools software from Syngene (Syngene,
Cambridge, UK).
RNA isolation and quantitative real-time PCR
Total RNA was isolated from HepG2 cells using TRIzol®
reagent (Invitrogen, Carlsbad, CA, USA) dissolved in
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structions. RNA (2 μg) was reverse-transcribed to cDNA
using oligo(dT) primers and moloney murine leukemia
virus reverse transcriptase (RT) in a final volume of
20 μl under the conditions recommended by the sup-
plier (Invitrogen). The resulting cDNA was amplified
using primers specific for PI3K or β-actin in a total vol-
ume of 10 μl. Quantitative real-time PCR was per-
formed using a Roche LightCycler 480 PCR system
using SYBR green fluorescence. The expression level of
PI3K was normalized to that of β-actin, which was used
as a specific endogenous control. Primer sequences
used were as follows:
PI3K forward 5′-TGG ACG GCG AAG TAA AGC
ATT-3′, reverse 5′-AGT GTG ACA TTG AGG GAG
TCG-3′; β-actin forward 5′-AGC CAT GTA CGT AGC
CAT CC-3′, reverse 5′- ACC CTC ATA GAT GGG
CAC AG-3′.Induction of metabolic syndrome in rats and experiment
protocol
Male Sprague Dawley rats (180-220 g) were obtained
from the Laboratory Animal Center of Guangzhou
University of Chinese Medicine (Guangzhou, Republic
of China). Rats were housed in a climate-controlled en-
vironment (25±1°C at 50% relative humidity) with 12-h
light/12-h dark cycles. Water was available ad libitum.
The model rats of metabolic syndrome (MS) were in-
duced by fed a high-fat diet (HFD) consisting of 40%
(wt/wt) fat for 12 consecutive weeks, while control rats
were fed normal chow. Then the MS rats were randomly
divided into 5 groups and treated with distilled water
(Group 1), FTZ -H (Group 2), FTZ -M (Group 3), FTZ -L
(Group 4) and aspirin (200 mg/kg) (Group 5), respect-
ively. FTZ with 6 g/kg, 3 g/kg and 1.5 g/kg were defined
as high, medium and low dosages, respectively. From
the fifth week to twelfth week, rats of FTZ groups were
treated by FTZ for 8 consecutive weeks. Then the rats
were used to measure body weight (BW) and serum
levels of total cholesterol (TC), triglycerides (TG) and
high-density lipoprotein cholesterol (HDL-C). Subse-
quently, all the rats were sacrificed and their epididymis
and kidney fat were excised for PI3K mRNA assay. The
animal care and study protocols were maintained in ac-
cordance with the provisions and general recommenda-
tion of the Chinese Regulations for the Administration of
Affairs Concerning Experimental Animals at Guangdong
Pharmaceutical University.Determination of body weight and biochemical indexes
During the animal experiments, body weight (BW) was
recorded at 0, 4, 8 and 12 weeks. Serum levels of total
cholesterol (TC), triglycerides (TG) and high-densitylipoprotein cholesterol (HDL-C) were analyzed using a
blood chemistry analyzer (Hitachi 7040).
Assessment of insulin resistance(IR)
Fasting plasma glucose level was measured via glucose
oxidase method. Fasting plasma insulin was measured
using radioimmunoassay method. IR was assessed ac-
cording to the homeostasis model assessment index
(HOMA-IR) calculated using the following formula:
(fasting plasma insulin level[μU/ml] × fasting plasma glu-
cose [mmol/l]) /22.5 [14].
RNA isolation and RT-PCR
Total RNA was isolated from adipose tissue using
TRIzol® reagent (Invitrogen, Carlsbad, CA, USA) dissolved
in DEPC-treated water according to the manufacturer’s
instructions. RNA (2 μg) was-reverse transcribed to
cDNA using oligo (dT) primers and moloney murine
leukemia virus reverse transcriptase (RT) in a final vol-
ume of 20 μl under the conditions recommended by
the supplier (Invitrogen). For polymerase chain reaction
(PCR) amplification of PI3K and β-actin, 1 μl of cDNA
template and the following specific primers were used:
PI-3K p85 forward 5’-GAA GGC AAC GAG AAG GA-3’,
reverse 5’-CAC AAG TGT CAG CCA CAT-3’ (213bp); β-
actin forward 5’-AGA TCT GGC ACC ACA CCT TCT
AC-3’, reverse 5’-TCA GGA TCT TCA TGA GGT AGT
CT-3’ (388bp). The reaction cycle conditions were: de-
naturation at 90°C for 50 s, annealing at 56.1°C for 50 s
and extension at 72°C for 50 s. The PCR products were re-
solved using a 2% agarose gel and visualized with ethidium
bromide staining. The expression level of PI3K was nor-
malized to that of β-actin, which was used as a specific en-
dogenous control.
Statistics
Statistical analyses were conducted using SPSS16.0 soft-
ware. All results are presented as the mean ± standard
deviation (SD). Statistical analysis was performed via
analysis of variance (one-way ANOVA) followed by the
Student-Newman-Keuls test for significance. Differences
were considered statistically significant at P< 0.05.
Results
Effect of FTZ on glucose content in insulin-resistant
HepG2 cells
The glucose content in insulin-resistant HepG2 cells in
culture medium significantly increased compared to that
of control cells. After treatment with FTZ (1, 25 and 100
μg/ml), glucose content in the culture medium signifi-
cantly decreased compared to that of IR cells (P<0.05).
RGS (10 μmol/l), used as a positive control drug, was
also able to increase glucose content in the culture
medium (Figure 1).
Figure 1 Effect of FTZ on glucose content in HepG2 cells.
HepG2 cells (2 × 105 cells/well) were incubated for 36 h in serum-free
DMEM containing 10-6mol/l insulin in the absence or presence
of FTZ or RGS. The content of glucose was quantified using a
GOD-POD kit. ΔP<0.05 compared to the control cells; *P <0.05
compared to the IR cells.
Figure 3 Effect of FTZ on IRS1 protein expression. The protein
expression of IRS1 was detected via western blotting as described in
the text. The figure represents one of three experiments with similar
results. Lane1, control; Lane2, IR (FTZ 0 μg/ml); Lane3, RGS 10 μmol/l;
Lane4, FTZ 100 μg/ml; Lane5, FTZ 25 μg/ml; Lane 6, FTZ 1 μg/ml.
ΔP<0.05 compared to the control cells; *P< 0.05 compared to the
IR cells.
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resistant HepG2 cells
To evaluate the effect of FTZ on PI-3K p85 mRNA ex-
pression, total RNA was extracted from HepG2 cells, and
real-time PCR was performed. As shown in Figure 2, PI-
3K p85 mRNA expression in HepG2 cells with IR was de-
creased compared to control cells (P<0.05 or P<0.01).
After treatment with FTZ, PI-3K p85 mRNA expression
significantly increased compared to IR cells (P<0.05).
These results suggest that FTZ induces an insulin sensitiz-
ing effect on IR cells through the up-regulation of PI-3K
p85 mRNA expression in HepG2 cells (Figure 2).
Effect of FTZ on IRS1 protein expression in HepG2 cells
with insulin resistance
To elucidate the effects of FTZ, western blot analysis
was used to measure IRS1 protein expression in HepG2Figure 2 Effect of FTZ on PI-3K p85 mRNA expression. The
expression of PI-3K p85 mRNA was detected via quantitative
real-time PCR as described in the text. ΔP <0.05 compared to the
control cells; *P <0.05, **P <0.01 compared to the IR cells.cells. As shown in Figure 3, IRS1 protein expression was
significantly reduced compared to control cells (P<0.05).
After treatment with FTZ, IRS1 protein expression was
significantly increased compared to IR cells (P<0.05)
(Figure 3).
Effect of FTZ on body weight of MS rats
After the rats were fed a high-fat diet for 12 continuous
weeks, our results indicated that the body weight ofFigure 4 Effect of FTZ on body weight of MS rats (g). The body
weight was recorded at 0, 4, 8, and 12 weeks. Aspirin (10 ml/kg/day),
used as a positive control drug, was able to decrease body weight
of MS rats. Data are mean ± SE (n = 10 for each group); *P<0.05,
**P<0.01 compared to the control rats; ΔP<0.05 compared to the
MS rats.
Figure 5 (See legend on next page.)
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Figure 5 Blood biochemical indexes (cholesterol, triglyceride and HDL-C) of MS rats. Blood samples were collected from the orbital sinus,
and cholesterol (a), triglyceride (b), HDL-C (c) levels were measured following administration of FTZ at 6 g/kg/day, 3 g/kg/day or 1.5 g/kg/day,
aspirin (AS) at 10 ml/kg/day or saline (control rats) for 8 consecutive weeks in high-fat diet-treated rats. *P<0.05, **P<0.01 compared to the control
rats; ΔP<0.05, ΔΔP<0.01 compared to the MS rats.
Figure 6 Other blood biochemical indexes (fasting glucose,
insulin and HOMA-IR index) of MS rats. Fasting plasma glucose
(FPG) level was measured via the glucose oxidase method. Fasting
plasma insulin (FPI) in rats was measured using a radioimmunoassay
method. To quantify the insulin resistance index, the following
formula was used: HOMA-IR = {(FPG*FPI)/22.5}. **P<0.01 compared
to the control rats; ΔP<0.05 compared to the MS rats.
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(P <0.05, P <0.01). After high, medium or low dosage
FTZ treatment for 4 consecutive weeks (equivalent to
the rats fed a high-fat diet for 8 weeks), the body weight
of the rats in the FTZ groups was significantly reduced
compared to that of MS rats. After FTZ treatment for 8
consecutive weeks (equivalent to the rats fed a high-fat
diet for 12 weeks), the high, medium and low dosage
FTZ-treated groups all possessed body weights which
were significantly reduced compared to the MS rats.
(P < 0.05, P < 0.01) (Figure 4).
Effect of FTZ on blood biochemical index of MS rats
Compared to the control rats, the levels of serum TG
and TC in MS rats were significantly increased (P<0.05
or P<0.01), while the level of serum HDL-C was signifi-
cantly reduced (P<0.05 or P<0.01). After treatment with
FTZ, the serum levels of TG and TC in MS rats were
significantly reduced (P<0.05 or P<0.01), and the serum
level of HDL-C was significantly increased (P<0.05 or
P<0.01). These results revealed that FTZ could alter the
serum levels of lipids in MS rats (Figure 5a-c).
Effect of FTZ on fasting glucose, insulin and HOMA-IR
index in MS rats
Compared to the control rats, levels of fasting glucose
and insulin, as well as the HOMA-IR index, were signifi-
cantly higher in MS rats (P<0.05 or P<0.01). After treat-
ment with the high dosage of FTZ or aspirin, the levels
of fasting glucose and insulin and HOMA-IR index were
all significantly reduced compared to the MS rats
(P<0.05 or P<0.01). After treatment with the medium
dosage of FTZ, the fasting glucose level and the
HOMA-IR index were significantly reduced compared
to the MS rats (P<0.05 or P<0.01). After treatment with
the low dosage of FTZ, the HOMA-IR index was signifi-
cantly reduced compared to the MS rats (P<0.05 or
P<0.01) (Figure 6).
Effect of FTZ on PI-3K p85 mRNA expression in adipose
tissue
To evaluate the effect of FTZ on PI-3K p85 mRNA ex-
pression, we performed RT-PCR in the adipose tissue of
rats. As shown in Figure 7, compared to the control rats,
the MS rats produced a lower expression level of PI-3K
p85 mRNA (P<0.05 or P<0.01). Administration of eitheraspirin or FTZ, the expression of PI-3K p85 mRNA was
increased compared to the MS rats (Figure 7).
Discussion
This study revealed that the Chinese herbal formula
FTZ could attenuate MS symptoms by decreasing the
content of glucose and lipids, and well as the insulin re-
sistance index. Additionally, its effects were possibly me-
diated through increased expression of PI-3Kp85 mRNA
and IRS1 protein in insulin-resistant HepG2 cells and
MS rats. Insulin resistance has been suggested as an
underlying cause of MS, including hyperglycemia, dyslip-
idemia and type 2 diabetes mellitus.
In our study, HepG2 cells were used as an insulin re-
sistance model to investigate the effect of FTZ on glu-
cose metabolism and insulin signaling. HepG2 cells
express PI-3Kp85 and IRS1 genes, which are involved in
the insulin signaling pathway [15,16]. Therefore, these
cells have been widely used to analyze glucose metabol-
ism, lipid metabolism, and insulin resistance [17,18].
Defects in the insulin signaling cascade, which lead to
impaired glucose utilization, were believed to play a key
role in the pathogenesis of insulin resistance [19]. It is con-
ceivable that IRS-1 tyrosine phosphorylation in response to
insulin stimulation generally increased the association of
IRS-1 with PI 3-kinase, resulting in increased PI 3-kinase
activity, which in turn led to activation of serine/threonine
kinase protein B (PKB or Akt) and, ultimately, to an
Figure 7 Effect of FTZ on PI-3K p85 mRNA expression. The
expression of PI-3K p85 mRNA was detected via RT-PCR as described
in the text. *P<0.05 compared to the control rats; ΔP <0.05,
ΔΔP<0.01 compared to the MS rats.
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Our research results revealed that the insulin receptor was
impaired, producing an insulin-resistant state in HepG2
cells under high insulin conditions. The expression of the
IRS-1 protein and IRS-1-associated PI-3K activity in
HepG2 cells were significantly decreased. After treatment
with FTZ, the expression of IRS-1 protein and PI-3K
mRNA were partially restored. Here, we revealed that the
FTZ-mediated recovery of insulin action was related to the
improvement of the IRS-1/PI 3-kinase signaling pathway
in insulin-resistant HepG2 cells. It appears that a FTZ-
mediated improvement in post-receptor insulin signaling
may have induced the subsequent increase in insulin
sensitivity.
In our study, MS model rats were induced via high-fat
diet feeding for 4 weeks. This model exhibited hyperin-
sulinemia, obesity, decreased insulin sensitivity, dyslipid-
emia and other features [21]. In our study, the MS rats
exhibited increased body weight, levels of serum TG and
total cholesterol, fasting glucose and plasma insulin, as
well as an increased insulin resistance index. This was
consistent with previous studies, such as I-Min Liu et al.
[22]. After treatment with FTZ, body weight, levels of
serum TG and TC, fasting glucose and plasma insulin
and the insulin resistance index were significantly re-
duced compared to MS rats. FTZ treatment also en-
hanced the activity of PI3K in adipose tissue compared
to MS rats.
Our study suggested that FTZ might ameliorate insu-
lin resistance and treat MS. This effect might be associ-
ated with the compounds which it contained. It hasbeen reported that oleanolic acid (OA) in Ligustrum luci-
dum W.T. Aiton decreased serum triglyceride, total chol-
esterol, LDL and free fatty acids, increased serum HDL
and reduced hepatic lipid accumulation. Furthermore,
inflammation in db/db mice was improved by OA, as ev-
idenced by decreased levels of IL-1 β, IL-6, and TNF-α
in the circulation and in the liver. These results sug-
gested that OA improved hepatic insulin resistance via
inhibition of mitochondrial ROS, hypolipidemia and
anti-inflammatory effects [23]. Ginsenoside Re in Panax
notoginseng (Burk.) F.H. Chen reduced insulin resistance
via activation of the PPAR-γ pathway by directly increas-
ing the expression of PPAR-γ2 and its responsive genes,
adiponectin, IRS-1 and ap2, inhibiting TNF-α produc-
tion and facilitating the translocation of GLUT4 to pro-
mote glucose uptake and disposal in 3T3-L1 adipocytes
[24]. Berberine in Coptis chinensis Franch. improved
insulin-induced tyrosine phosphorylation of IRS-1 and
the recruitment of p85 to IRS-1. The ameliorated insulin
signal transduction was related to berberine-mediated
inhibition of mTOR, which attenuated serine phosphor-
ylation of IRS-1. These results suggested that berberine
might ameliorate insulin resistance by modulating key
molecules in the insulin signaling pathway, leading to in-
creased glucose uptake in insulin-resistant cells [25].
Therefore, we suspect that these ingredients might explain
the role of FTZ in ameliorating insulin resistance.Conclusion
In conclusion, our study indicated that FTZ could de-
crease serum triglyceride, total cholesterol and fasting
blood glucose and increase serum HDL-C, thereby re-
activating the insulin-stimulated IRS1/PI3K pathway in
insulin-resistant HepG2 cells and up-regulating PI3K ex-
pression in adipose tissue. Therefore, the beneficial ef-
fects of FTZ on insulin resistance suggest that this
decoction may be a promising therapeutic for MS and
insulin resistance.
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